IPSOS: A Phase III, Global, Multicentre, Open-Label, Randomised, Controlled Study of First-Line Atezolizumab Versus Single-Agent Chemotherapy in Patients with Non-Small Cell Lung Cancer Ineligible for Treatment with a Platinum-Containing Regimen
Siow Ming Lee, Christian Klaus Jochen Schulz, Kumar Prabhash et al. · SSRN Electronic Journal · 2022
Cited by 2 works. doi:10.2139/ssrn.4307691
Authors
- Siow Ming Lee
- Christian Klaus Jochen Schulz
- Kumar Prabhash
- Dariusz Mirosław Kowalski
- Aleksandra Szczęsna
- Baohui Han
- Achim Rittmeyer
- Toby Talbot
- David Vicente
- Raffaele Califano
- Diego Luigi Cortinovis
- Dingzhi Huang
- Geoffrey Liu
- Federico Cappuzzo
- Jessica Reyes Contreras
- Martin Reck
- Ramón Palmero
- Milena Perez Mak
- Youyou Hu